Vensana Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
9
- Investments
-
38
- Portfolio
-
19
- Exits
-
9
Vensana Capital General Information
Company Description
Founded in 2019, Vensana Capital is a venture capital and growth equity firm based in Minneapolis, Minnesota. The firm seeks to invest in medtech companies operating in the medical devices, data science-oriented solutions, life science tools & diagnostics, and tech-enabled services sectors. This firm is a Registered Investment Adviser (RIA).
Business Details
Investor Status
Trade Association
Primary Investor Type
Other Investor Types
Corporate Office
- 3601 West 76th Street
- Suite 20
- Minneapolis, MN 55435
- United States
Vensana Capital Investments (38)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| TYBR Health | 21-Jul-2026 | Later Stage VC | Medical Supplies | Pre-Clinical Trials | ||
| Ventaris Surgical | 02-Mar-2026 | Surgical Devices | Clinical Trials - General | |||
| Apella (Other Healthcare Technology Systems) | 08-Jan-2026 | Enterprise Systems (Healthcare) | Generating Revenue | |||
| Okami Medical | 19-Nov-2025 | Surgical Devices | Generating Revenue | |||
| Abrus Bio | 01-Sep-2025 | Other Commercial Products | Stealth | |||
| Luna Diabetes | 12-Aug-2025 | Other Healthcare Technology Systems | Generating Revenue | |||
| SpyGlass Pharma | 01-Jun-2025 | Surgical Devices | Generating Revenue | |||
| Rampart (Diagnostic Equipment) | 24-Apr-2025 | Diagnostic Equipment | Generating Revenue | |||
| Evident Vascular | 25-Mar-2025 | Early Stage VC | Diagnostic Equipment | Generating Revenue | ||
| ChromaCode | 30-Jan-2025 | Later Stage VC | Diagnostic Equipment | Generating Revenue |
Vensana Capital Exits (9)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Moxe | 05-Mar-2026 | Buyout/LBO | |
| SpyGlass Pharma | 05-Feb-2026 | ||
| Artelon | 11-Jul-2024 | ||
| Relievant | 17-Nov-2023 | ||
| Monteris Medical | 01-May-2022 | ||
| Personal Genome Diagnostics | 18-Feb-2022 | ||
| Vesper Medical | 11-Jan-2022 | ||
| CVRx | 30-Jun-2021 | IPO | |
| Intact Vascular | 04-Sep-2020 | Merger/Acquisition |
Vensana Capital Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
Vensana Capital Investments by Industry, Year, and Region
Vensana Capital Co-Investors (68)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Gilde Healthcare | 4 |
|
|
||
| Broadview Ventures |
|
|
|||
| Piper Sandler |
|
|
|||
| Sands Capital |
|
|
|||
| ShangBay Capital |
|
|
Vensana Capital FAQs
-
What is Vensana Capital?
Founded in 2019, Vensana Capital is a venture capital and growth equity firm based in Minneapolis, Minnesota.
-
When was Vensana Capital founded?
Vensana Capital was founded in 2019.
-
Where is Vensana Capital headquartered?
Vensana Capital is headquartered in Minneapolis, MN.
-
What is Vensana Capital's total asset value?
Vensana Capital has around in total assets under management.
-
How many investments has Vensana Capital made?
Vensana Capital has made 38 investments.
-
What has Vensana Capital invested in?
Vensana Capital has made numerous investments in companies like TYBR Health, Ventaris Surgical, and Apella (Other Healthcare Technology Systems) within the Medical Supplies, Surgical Devices, and Enterprise Systems (Healthcare) industries.
-
What has Vensana Capital invested in recently?
Vensana Capital's latest investment was on 21-Jul-2026 in TYBR Health, a company within the Medical Supplies industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process